Onconova Therapeutics, Inc. — Form D

Onconova Therapeutics, Inc. of NEWTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-16. The offering totals $14.0M, of which $14.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (63)

Showing 25 of 63 people.

NameRoleLocation
Werner CautreelsDirectorWaltham, MA
Trafford ClarkeDirectorNewtown, PA
Ian DukesDirectorNewtown, PA
James MarinoDirectorNewtown, PA
Nikolay SavchukDirectorDover, DE
M. Theresa ShoemakerDirectorNewtown, PA
Jack E StoverDirectorParsippany, NJ
Werner CautreelsExecutive OfficerWaltham, MA
Steven FruchtmanExecutive OfficerNewtown, PA
Mark GuerinExecutive OfficerNewtown, PA
David PauzaExecutive OfficerNewtown, PA
Robert RedfieldExecutive OfficerNewtown, PA
Nikolay SavchukExecutive OfficerDover, DE
Pankaj PatelDirectorYardley, PA
Michael M HoffmanDirectorVancouver, A1
Viren MehtaDirectorJUPITER, FL
Michael B HoffmanDirectorNewtown, PA
Jerome E GroopmanDirectorNewtown, PA
Abraham N OlerExecutive OfficerNewtown, PA
Viren N MehtaDirectorNewtown, PA
James J MarinoDirectorNewtown, PA
Premkumar J ReddyDirectorNewtown, PA
Steven M FruchtmanDirectorNewtown, PA
Steven M FruchtmanExecutive OfficerNewtown, PA
Manoj M ManiarExecutive OfficerNewtown, PA

Other filings by this issuer (10)

FiledFormOfferingSold
2019-06-04D$2.0M$500K
2018-06-08D$1.3M$1.3M
2015-10-23D$16.5M$1.5M
2012-08-13D$50.0M$50.0M
2012-07-26D/A$30.0M$26.4M
2012-05-10D$30.0M$7.0M
2011-01-05D/A$20.0M$11.7M
2010-10-04D$15.0M$6.5M
2010-03-04D/A$26.3M$19.2M
2009-05-26D$23.5M$5.3M

More